VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate.
Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate. Blood. 2006 Jan 15; 107(2):480-2.
View in:
PubMed
subject areas
Adult
Antineoplastic Agents
Benzamides
Blast Crisis
Cytogenetic Analysis
Disease-Free Survival
Female
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lymphocyte Activation
Male
Middle Aged
Neoplasm Recurrence, Local
Piperazines
Protein-Tyrosine Kinases
Pyrimidines
Remission Induction
Survival Rate
Transplantation, Homologous
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES
SRDAN VERSTOVSEK
GUILLERMO GARCIA-MANERO
ELIAS JOSEPH JABBOUR